ArticleArthritis research & therapy2021

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.

Sofia Ajeganova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.